IP Verse

Seqirus Uk patent opposition analysis

Get complete Patent Opposition Report for Seqirus Uk

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Seqirus Uk

Explore patent oppositions filed by Seqirus Uk against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3283059	Method For Producing Rna Compositions	CUREVAC	Oct 1, 2024
EP2791160	Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions	MODERNA THERAPEUTICS	Dec 1, 2022
EP3134131	Nucleic Acid Vaccines	MODERNATX	Sep 21, 2022
EP3682905	Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof	MODERNATX	Sep 1, 2022

Latest patents of Seqirus Uk opposed by its competitors

Explore Seqirus Uk's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3489211	Jul 15, 2020	Improved Methods For Preparing Squalene	1
EP2614835	Aug 21, 2019	Vaccination With Multiple Clades Of H5 Influenza A Virus	1
EP3103784	Feb 6, 2019	Manufacture Of An Oil-In-Water Emulsion Comprising Squalene	1

Top competitors of Seqirus Uk

GLAXOSMITHKLINE BIOLOGICALS

MODERNATX

CUREVAC